Antipsychotic off-label use in the 21st century: An enduring public health concern
Soon after the introduction of second-generation antipsychotics, antipsychotic off-label use (OLU) progressively became a common prescribing practice. This evolving practice should be regularly monitored considering the growing number of persons exposed to the adverse effects of antipsychotics. The...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Taylor & Francis Group
2025-12-01
|
| Sarja: | Dialogues in Clinical Neuroscience |
| Aiheet: | |
| Linkit: | https://www.tandfonline.com/doi/10.1080/19585969.2025.2449833 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|